CUSIP: 87164U102
Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,648,487
-
Share change
-
0
-
Total reported value
-
$31,572,444
-
Price per share
-
$1.53
-
Number of holders
-
27
Quarterly Holders Quick Answers
What is CUSIP 87164U102?
CUSIP 87164U102 identifies SYN - SYNTHETIC BIOLOGICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2014
-
Previous quarter:
Q3 2013
Recent filing periods for CUSIP 87164U102:
Institutional Holders of SYNTHETIC BIOLOGICS INC - COM (SYN) as of Q4 2013
As of 31 Dec 2013,
SYNTHETIC BIOLOGICS INC - COM (SYN) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,648,487 shares.
The largest 10 holders included
Third Security, LLC, MSDC Management, L.P., Knoll Capital Management, LP, Belmont Global Advisors, Inc., ROYCE & ASSOCIATES LLC, VANGUARD GROUP INC, Janney Montgomery Scott LLC, BANK OF AMERICA CORP /DE/, DAFNA Capital Management LLC, and LMR Master Fund Ltd.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.